Ananda Pharma Plc (AQU:ANA)

Ananda Pharma Cash Flow Statement

Financials in millions GBP. Fiscal year is February - January.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jan 31, 2024	Jan 31, 2023	Jan 31, 2022	Jan 31, 2021	Jan 31, 2020
Net Income	-6.15	-1.3	-	-	-0.37
Depreciation & Amortization	0.56	0.17	-	-	-
Asset Writedown & Restructuring Costs	4.55	0.04	-	-	-
Stock-Based Compensation	0.02	0.01	-	-	-
Other Operating Activities	-0.79	0.42	-	-	0.01
Change in Accounts Receivable	0.14	-0.14	-	-	-0.32
Change in Accounts Payable	0.95	0.34	-	-	0.17
Operating Cash Flow	-0.72	-0.46	-	-	-0.51
Capital Expenditures	-0	-	-	-	-
Cash Acquisitions	0.02	0.03	-	-	-
Investment in Securities	-	-1.48	-	-	-
Other Investing Activities	0	-	-	-	-
Investing Cash Flow	0.02	-1.45	-	-	-
Long-Term Debt Issued	0.3	1.89	-	-	-
Long-Term Debt Repaid	-	-0.04	-	-	-
Net Debt Issued (Repaid)	0.3	1.85	-	-	-
Issuance of Common Stock	0.47	0.07	-	-	0.4
Financing Cash Flow	0.77	1.92	-	-	0.4
Net Cash Flow	0.07	0.02	-	-	-0.11
Free Cash Flow	-0.72	-0.46	-	-	-0.51
Free Cash Flow Per Share	-	-0.00	-	-	-0.00
Levered Free Cash Flow	-0.94	-0.41	-	-	-0.02
Unlevered Free Cash Flow	-0.85	-0.25	-	-	-0.02
Change in Net Working Capital	-0.43	-0.19	-0.2	-0.12	-0.22

Updated Oct 29, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.